Usefulness of surface electrocardiogram in predicting the clinical course of patients with hypertrophic cardiomyopathy

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue SUPPL. 1, 2007, Pages 178-181

  Bayrak, Fatih ^a   Kahveci, Gökhan ^b   Mutlu, Bülent ^b   Deǧertekin, Muzaffer ^a   Demirtaş, Ertan ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hypertrophic cardiomyopathy; Prognosis; QT dispersion

Indexed keywords

ADOLESCENT; ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; QT DISPERSION; QT INTERVAL; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SYMPTOM;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TURKEY;

EID: 34447106153     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003; 42: 1687-713.
2. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348: 295-303.
3. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 45; 697-704.
4. Fauchier JP, Fauchier L, Babuty D, Cosnay P. Time-domain signal averaged electrocardiogram in nonischemic ventricular tachycardia. Pacing Clin Electrophysiol 1996; 19: 231-44.
5. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72: 973-6.
6. Yi G, Elliott P, McKenna WJ, Prasad K, Sharma S, Guo XH, et al. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 1514-9.
7. Maron BJ, Leyhe MJ 3rd, Casey SA, Gohman TE, Lawler CM, Crow RS, et al. Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. Am J Cardiol 2001; 87: 114-5.
8. Goktekin O, Ritsushi K, Matsumoto K, Hiroshi M. The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy. Anadolu Kardiyol Derg 2002; 2: 226-30.
9. Kuroda N, Ohnishi Y, Yoshida A, Kimura A, Yokoyama M. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy. Circ J 2002; 66: 457-62.
10. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-708.
11. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-85.
12. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001; 104: 128-30.
13. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-4.
14. Davey PP, Bateman J, Mulligan IP, Forfar C, Barlow C, Hart G. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: Relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 1994; 71: 268-73.
15. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327-9.
16. Grimm W, Steder U, Menz V, Hoffmann J, Grote F, Maisch B. Clinical significance of increased QT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy. Pacing Clin Electrophysiol 1996; 19 (Pt II): 1886-9.
17. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiologic findings. Circulation 1992; 86: 730-40.
18. Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004; 109: 984-9.
19. de Carvalho FC, Consolim-Colombo FM, Pastore CA, Rubira MC, Meneguetti JC, Krieger EM, et al. Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failure. Am J Physiol Heart Circ Physiol 2005; 288: H2171-6.
20. Yee KM, Lim PO, Ogston SA, Struthers AD. Effect of phenylephrine with and without atropine on QT dispersion in healthy normotensive men. Am J Cardiol 2000; 85: 69-74.
21. Hiasa G, Hamada M, Saeki H, Ogimoto A, Ohtsuka T, Hara Y, et al. Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy. Chest 2004; 126: 679-86.